Chisholm GD - Search Results

1

Results of conservative management of clinically localized prostate cancer.

Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM, Warner J. Chodak GW, et al. Among authors: chisholm gd. N Engl J Med. 1994 Jan 27;330(4):242-8. doi: 10.1056/NEJM199401273300403. N Engl J Med. 1994. PMID: 8272085 Free article.

2

The TNM system of 1992. Comments from the TNM working group. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.

Chisholm GD, Hedlund PO, Adolfsson J, Denis LJ, Friberg S, Johansson JE, Peeling B. Chisholm GD, et al. Scand J Urol Nephrol Suppl. 1994;162:107-14; discussion 115-27. Scand J Urol Nephrol Suppl. 1994. PMID: 7529428 Review.

3

Is the outcome of conservative management for localized prostate cancer acceptable? An overview.

Chisholm GD, Rana A. Chisholm GD, et al. Eur Urol. 1993;24 Suppl 2:64-6. doi: 10.1159/000474393. Eur Urol. 1993. PMID: 8262128

4

Conservative management with symptomatic treatment and delayed hormonal manipulation is justified in men with locally advanced carcinoma of the prostate.

Rana A, Chisholm GD, Khan M, Rashwan HM, Elton RA. Rana A, et al. Among authors: chisholm gd. Br J Urol. 1994 Nov;74(5):637-41. doi: 10.1111/j.1464-410x.1994.tb09197.x. Br J Urol. 1994. PMID: 7827816

5

Audit and its impact in the management of early prostatic cancer.

Rana A, Chisholm GD, Christodoulou S, McIntyre MA, Elton RA. Rana A, et al. Among authors: chisholm gd. Br J Urol. 1993 Jun;71(6):721-7. doi: 10.1111/j.1464-410x.1993.tb16073.x. Br J Urol. 1993. PMID: 8343901

6

Symptomatology of metastatic prostate cancer: prognostic significance.

Rana A, Chisholm GD, Rashwan HM, Salim A, Merrick MV, Elton RA. Rana A, et al. Among authors: chisholm gd. Br J Urol. 1994 Jun;73(6):683-6. doi: 10.1111/j.1464-410x.1994.tb07556.x. Br J Urol. 1994. PMID: 8032836

7

The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer.

Paul AB, Love C, Chisholm GD. Paul AB, et al. Among authors: chisholm gd. Br J Urol. 1994 Nov;74(5):642-5. doi: 10.1111/j.1464-410x.1994.tb09198.x. Br J Urol. 1994. PMID: 7827817

8

Prostate cancer.

Chisholm G, Rana A. Chisholm G, et al. Practitioner. 1992 Jun;236(1515):610-7. Practitioner. 1992. PMID: 1454729 No abstract available.

9

Audit and its impact in the management of advanced prostatic cancer.

Rana A, Chisholm GD, Christodoulou S, McIntyre M, Elton RA. Rana A, et al. Among authors: chisholm gd. Br J Urol. 1993 Oct;72(4):478-83. doi: 10.1111/j.1464-410x.1993.tb16181.x. Br J Urol. 1993. PMID: 8261306

10

De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease.

Cumming JA, Ritchie AW, Goodman CM, McIntyre MA, Chisholm GD. Cumming JA, et al. Among authors: chisholm gd. Br J Urol. 1990 Mar;65(3):271-4. doi: 10.1111/j.1464-410x.1990.tb14725.x. Br J Urol. 1990. PMID: 2337747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters